Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
type: MedicalStudy
description: A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2005-05
end date: 2006-10
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00295854
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: MediciNova
study subject: Interstitial Cystitis
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Interstitial Cystitis

AI Analytics
type: Organization